{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:19:48Z","timestamp":1791181188360,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.molimm.2007.03.020","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T13:33:38Z","timestamp":1178631218000},"page":"3789-3796","source":"Crossref","is-referenced-by-count":15,"title":["A novel human scFv fragment against TNF-\u03b1 from de novo design method"],"prefix":"10.1016","volume":"44","author":[{"given":"Hong","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beifen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2007.03.020_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","article-title":"The biology of cachetin\/TNF. A primary mediator of the host response","volume":"7","author":"Beutler","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2007.03.020_bib2","first-page":"16","article-title":"The role of tumor necrosis factor in health and disease","volume":"26","author":"Beutler","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2007.03.020_bib3","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.87.8.3127","article-title":"Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies","volume":"87","author":"Brockhaus","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2007.03.020_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0006-291X(03)01131-8","article-title":"A peptide mimetic of an anti-CD4 monoclonal antibody by rational design","volume":"307","author":"Casset","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2007.03.020_bib5","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","article-title":"A domain in TNF receptors that mediates ligand independent receptor assembly and signaling","volume":"288","author":"Chan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molimm.2007.03.020_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2567.1999.00660.x","article-title":"A phage-displayed mimotope inhibits tumor necrosis factor-induced cytotoxicity more effectively than the free mimotope","volume":"96","author":"Chirinos-Rojas","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2007.03.020_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0161-5890(94)90101-5","article-title":"Identification and characterization of a TNF alpha antagonist derived from a monoclonal antibody","volume":"31","author":"Doring","year":"1994","journal-title":"J. Mol. Immunol."},{"key":"10.1016\/j.molimm.2007.03.020_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2007.03.020_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.imlet.2004.12.006","article-title":"Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design","volume":"98","author":"Feng","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2007.03.020_bib10","doi-asserted-by":"crossref","first-page":"29897","DOI":"10.1074\/jbc.M202359200","article-title":"Kinetic and affinity predictions of a protein\u2013protein interaction using multivariate experimental design","volume":"277","author":"Genst","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.molimm.2007.03.020_bib11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molimm.2007.03.020_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2007.03.020_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jmbi.1999.3444","article-title":"Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides","volume":"296","author":"Knappik","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2007.03.020_bib14","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2007.03.020_bib15","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2007.03.020_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2007.03.020_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bcp.2005.07.032","article-title":"New class of linoleic acid metabolites biosynthesized by corn and rice lipoxygenases: suppression of proinflammatory mediator expression via attenuation of MAPK- and Akt-, but not PPAR\u03b3-, dependent pathways in stimulated macrophages","volume":"70","author":"Murakami","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molimm.2007.03.020_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0006-2952(03)00419-2","article-title":"Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor kappa B activation and inflammatory cytokine expression in macrophages","volume":"66","author":"Murakami","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molimm.2007.03.020_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","article-title":"Anti-TNF-\u03b1 therapies: the next generation","volume":"2","author":"Palladino","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molimm.2007.03.020_bib20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbrc.2004.07.208","article-title":"A novel TNF-\u03b1 antagonizing peptide-Fc fusion protein designed based on CDRs of TNF-\u03b1 neutralizing monoclonal antibody","volume":"322","author":"Qin","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2007.03.020_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.molimm.2005.04.009","article-title":"Fusion protein of CDR mimetic peptide with Fc inhibit TNF-\u03b1 induced cytotoxicity","volume":"43","author":"Qin","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2007.03.020_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbiotec.2006.01.036","article-title":"De novo design TNF-\u03b1 antagonistic peptide based on the complex structure of TNF-\u03b1 with its neutralizing monoclonal antibody Z12","volume":"125","author":"Qin","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.molimm.2007.03.020_bib23","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.molimm.2006.10.016","article-title":"A novel domain antibody rationally designed against TNF-\u03b1 using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides","volume":"44","author":"Qin","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2007.03.020_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1099-1352(200007\/08)13:4<167::AID-JMR502>3.0.CO;2-9","article-title":"Engineered protein scaffolds for molecular recognition","volume":"13","author":"Skerra","year":"2000","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.molimm.2007.03.020_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/1097-0029(20000801)50:3<196::AID-JEMT3>3.0.CO;2-9","article-title":"Role of TNF in lymphocyte-mediated cytotoxicity","volume":"50","author":"Smyth","year":"2000","journal-title":"Microsc. Res. Technol."},{"key":"10.1016\/j.molimm.2007.03.020_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"Steed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molimm.2007.03.020_bib27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nbt1197-1266","article-title":"Structure based design and characterization of exocyclic peptidomimetics that inhibit TNF-\u03b1 binding to its receptor","volume":"15","author":"Takasaki","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molimm.2007.03.020_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-6147(99)01414-5","article-title":"Rational design of peptide agonists of cell-surface receptors","volume":"21","author":"Taylor","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molimm.2007.03.020_bib29","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1016\/S0021-9258(19)67772-0","article-title":"Design of bioactive peptides based on antibody hypervariable region structures","volume":"266","author":"William","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2007.03.020_bib30","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.86.14.5537","article-title":"Development of biologically active peptides based on antibody structure","volume":"86","author":"Williams","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2007.03.020_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1126\/science.7678469","article-title":"Presentation of a viral T cell epitope expressed in the CDR3 region of a self-immunoglobulin molecule","volume":"259","author":"Zaghouani","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molimm.2007.03.020_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/355476a0","article-title":"Antigenized antibodies","volume":"355","author":"Zanetti","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2007.03.020_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.1992.tb01524.x","article-title":"Theoretical and practical aspects of antigenized antibodies","volume":"130","author":"Zanetti","year":"1992","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2007.03.020_bib34","first-page":"167","article-title":"Identification of binding epitope of a monoclonal antibody (Z12) against human TNF-\u03b1 using computer modeling and deletion mutant technique","volume":"47","author":"Zhang","year":"2004","journal-title":"Sci. China Ser. C"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589007001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589007001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T05:58:51Z","timestamp":1628834331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589007001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0161589007001356"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2007.03.020","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}